
    
      Aims:

        1. To compare the efficacy of the vaginal and sublingual administration of the synthetic
           prostaglandin misoprostol with the currently used vaginal administration route in second
           trimester pregnancy termination.

        2. To compare the impact of gestation of the duration of abortion within these three
           misoprostol regimens.

        3. To compare the incidence of maternal side-effects between the three routes of
           prostaglandin administration.

        4. To compare the incidence of placental retention and need for curettage between the three
           groups
    
  